Thrombosis Research Institute
BARCELONA, Spain -
- Six-year GARFIELD Registry to prospectively follow 50,000 AF patients worldwide -
The Thrombosis Research Institute (TRI) - an affiliated institute of Queen Mary University of London - today announced the launch of GARFIELD (Global Anticoagulant Registry in the Field), an innovative research initiative to understand the burden of atrial fibrillation (AF) on a global scale.